Utah Tech Gets First NIH Grant for Zebrafish Study
The just over $1 million award supports research into 4H leukodystrophy, a rare genetic brain disorder with no known cure.
Updated on Nov. 21, 2026 in Life Sciences

Utah Tech University received its first National Institutes of Health research grant of just over $1 million in September 2026. The funding supports the lab of biology assistant professor Hung-Yu Shih, which uses zebrafish to study 4H leukodystrophy.
Why it matters
4H leukodystrophy is a rare, fatal-in-childhood disease that currently has no known cure, so new research tools are significant for families affected by it. The project also marks a milestone for Utah Tech as it expands its federally funded research activity.
The award is a federal NIH research grant totaling just over $1 million, the first of its kind for Utah Tech University. Whether the research will produce a viable treatment for 4H leukodystrophy remains unknown, as developing one will take time.
The players
Utah Tech University
A public university in Saint George, Utah, that is receiving its first National Institutes of Health research grant.
Hung-Yu Shih
An assistant professor of biology at Utah Tech University whose lab leads the zebrafish research on 4H leukodystrophy.
National Institutes of Health
The U.S. federal agency that funds biomedical and public health research, including this grant to Utah Tech University.
The details
Shih's team used CRISPR gene editing to switch off one gene in zebrafish, producing fish with less myelin and altered tooth shape. The researchers are now studying how deficiencies in multiple genes contribute to the disease, and plan to test whether drugs already approved for other conditions can ease its effects in the fish.
Timeline
September 2026: Utah Tech University received its first NIH research grant.
Early infancy: Symptoms of 4H leukodystrophy typically begin to appear.
Big Picture
The award places Utah Tech among the institutions receiving National Institutes of Health funding for biomedical research, a federal program that supports studies of rare genetic disorders. The grant extends that federal support to a regional university research lab working on zebrafish models.
For families affected by 4H leukodystrophy, the research offers no immediate change to care, since the disease currently has no known cure. Shih and his students plan to test whether existing approved drugs can ease effects in the fish, a step that could eventually inform future treatment options.
The takeaway
Federal research funding can reach regional universities, and early-stage animal models like zebrafish are one way scientists test possible treatments for rare diseases. Readers following genetic disorder research should expect progress to be gradual.
Further reading
Explore more Life Sciences coverage for background on how researchers study genetic disorders.
Source note: This article includes information reported by Utah Public Radio.






